Nanotechnology-based combinational drug delivery: An emerging approach for cancer therapy

Drug Discovery Today

Volumn 17, Issue 17-18, 2012, Pages 1044-1052

  Parhi, Priyambada ^a   Mohanty, Chandana ^a   Sahoo, Sanjeeb Kumar ^a  

^a INSTITUTE OF LIFE SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BREAST CANCER RESISTANCE PROTEIN; CANCER VACCINE; CARBON NANOTUBE; CARBOPLATIN; CELECOXIB; CURCUMIN; CYTARABINE; DAUNORUBICIN; ELACRIDAR; EMODIN; EVEROLIMUS; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; METHOTREXATE; MITOMYCIN C; MULTIDRUG RESISTANCE PROTEIN 1; NAVELBINE; PACLITAXEL; PROSTATE SPECIFIC ANTIGEN; RALOXIFENE; RETINOIC ACID; TAMOXIFEN; TARIQUIDAR; TAXANE DERIVATIVE; TOPOTECAN; UNINDEXED DRUG; ZOLEDRONIC ACID; ZOSUQUIDAR;

ABSENCE OF SIDE EFFECTS; ACUTE GRANULOCYTIC LEUKEMIA; ADVANCED CANCER; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTINEOPLASTIC ACTIVITY; ANUS CANCER; BILE DUCT CARCINOMA; BREAST CANCER; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RELAPSE; CANCER SURVIVAL; CELL KILLING; CELL STRAIN K 562; CHEMORADIOTHERAPY; CHILDHOOD LEUKEMIA; COLON CANCER; DRUG BIOAVAILABILITY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG TARGETING; GENE MUTATION; GLIOBLASTOMA; HELA CELL; HODGKIN DISEASE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; LYMPHOMA CELL LINE; METASTASIS; MICELLE; MULTIDRUG RESISTANCE; MULTIPLE CYCLE TREATMENT; NANOTECHNOLOGY; NONHODGKIN LYMPHOMA; NONHUMAN; OVARY CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PNEUMONIA; PROSTATE CANCER; QUALITY OF LIFE; RADIOSENSITIZATION; REVIEW;

ANIMALS; COMBINED MODALITY THERAPY; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS;

EID: 84865480687     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.05.010     Document Type: Review

References (64)

1. M. Das Ligand-based targeted therapy for cancer tissue Expert Opin. Drug Deliv. 6 2009 285 304
2. C. Mohanty Receptor mediated tumor targeting: an emerging approach for cancer therapy Curr. Drug Deliv. 8 2011 45 58
3. A. Persidis Cancer multidrug resistance Nat. Biotechnol. 17 1999 94 95 (Pubitemid 29037219)
4. S. Parveen, and S.K. Sahoo Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs Clin. Pharmacokinet. 45 2006 965 988 (Pubitemid 44436001)
5. S. Parveen, and S.K. Sahoo Polymeric nanoparticles for cancer therapy J. Drug Target. 16 2008 108 123 (Pubitemid 351266548)
6. S.K. Sahoo The present and future of nanotechnology in human health care Nanomedicine 3 2007 20 31 (Pubitemid 46428187)
7. J. Lehar Synergistic drug combinations tend to improve therapeutically relevant selectivity Nat. Biotechnol. 27 2009 659 666
8. R. Misra Cancer nanotechnology: application of nanotechnology in cancer therapy Drug Discov. Today 15 2010 842 850
9. S.K. Sahoo Nanotechnology in ocular drug delivery Drug Discov. Today 13 2008 144 151
10. T.C. Chou Drug combination studies and their synergy quantification using the Chou-Talalay method Cancer Res. 70 2010 440 446
11. G.H. Lai Celecoxib acts in a cyclooxygenase-2-independent manner and in synergy with emodin to suppress rat cholangiocarcinoma growth in vitro through a mechanism involving enhanced Akt inactivation and increased activation of caspases-9 and -3 Mol. Cancer Ther. 2 2003 265 271
12. C.T. Chiang Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma Cancer Lett. 298 2010 195 203
13. H. Lage An overview of cancer multidrug resistance: a still unsolved problem Cell Mol. Life Sci. 65 2008 3145 3167
14. J. Robert, and C. Jarry Multidrug resistance reversal agents J. Med. Chem. 46 2003 4805 4817 (Pubitemid 37352018)
15. M. Hubensack Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice J. Cancer Res. Clin. Oncol. 134 2008 597 607 (Pubitemid 351422612)
16. J.E. Lancet A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia Leuk. Res. 33 2009 1055 1061
17. C.A. Dasanu Carboplatin-gemcitabine in the therapy of advanced ovarian cancer: dose reduction consideration J. Oncol. Pharm. Pract. 16 2010 63 66
18. S.V. Bava Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization J. Biol. Chem. 280 2005 6301 6308 (Pubitemid 40341176)
19. J.F. Logman Economic evaluation of zoledronic acid for the prevention of osteoporotic fractures in postmenopausal women with early-stage breast cancer receiving aromatase inhibitors in the UK Ann. Oncol. 21 2010 1529 1536
20. B. Pauwels Combined modality therapy of gemcitabine and radiation Oncologist 10 2005 34 51 (Pubitemid 40171250)
21. N.D. Nigro Combined therapy for cancer of the anal canal: a preliminary report Dis. Colon Rectum 17 1974 354 356
22. L.M. DeAngelis Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10 J. Clin. Oncol. 20 2002 4643 4648
23. J.L. Gulley Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer Clin. Cancer Res. 11 2005 3353 3362 (Pubitemid 40627887)
24. F. Greco, and M.J. Vicent Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines Adv. Drug Deliv. Rev. 61 2009 1203 1213
25. M. Tanabe Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes Breast Cancer 16 2009 301 306
26. H.T. Arkenau 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial Ann. Oncol. 14 2003 395 399 (Pubitemid 36367416)
27. M. Berhoune Therapeutic strategy for treatment of metastatic non-small cell lung cancer Ann. Pharmacother. 42 2008 1640 1652
28. S.K. Sahoo, and V. Labhasetwar Nanotech approaches to drug delivery and imaging Drug Discov. Today 8 2003 1112 1120 (Pubitemid 37547917)
29. C.M. Hu Nanoparticle-assisted combination therapies for effective cancer treatment Therapeutic Deliv. 1 2010 323 334
30. N.K. Narayanan Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice Int. J. Cancer 125 2009 1 8
31. J. Wu Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil J. Pharm. Pharm. Sci. 10 2007 350 357 (Pubitemid 350065179)
32. A. Dicko Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo Expert Opin. Drug Deliv. 7 2010 1329 1341
33. G. Batist Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors Clin. Cancer Res. 15 2009 692 700
34. G. Dykes Dendrimers: a review of their appeal and applications J. Chem. Technol. Biotechnol. 76 2001 903 918 (Pubitemid 32825595)
35. A.R. Menjoge Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications Drug Discov. Today 15 2010 171 185
36. R.K. Tekade Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics J. Microencapsul. 26 2009 287 296
37. F. Wang Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance Biomaterials 32 2011 9444 9456
38. U. Katragadda Multi-drug delivery to tumor cells via micellar nanocarriers Int. J. Pharm. 419 2011 281 286
39. H.C. Shin A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs Mol. Pharm. 8 2011 1257 1265
40. R. Li P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells ACS Nano 4 2010 1399 1408
41. S. Dhar Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device J. Am. Chem. Soc. 130 2008 11467 11476
42. H. Maeda Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS J. Control. Release 74 2001 47 61 (Pubitemid 32727608)
43. T. Lammers Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers Biomaterials 30 2009 3466 3475
44. C.F. Verschraegen A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors Cancer Chemother. Pharmacol. 63 2009 903 910
45. H. Krakovicova HPMA-based polymer conjugates with drug combination Eur. J. Pharm. Sci. 37 2009 405 412
46. S. Acharya, and S.K. Sahoo Sustained targeting of Bcr-Abl + leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapy Biomaterials 32 2011 5643 5662
47. R. Misra, and S.K. Sahoo Coformulation of doxorubicin and curcumin in poly(d,l-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells Mol. Pharm. 8 2011 852 866
48. S. Yadav Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells Cancer Chemother. Pharmacol. 63 2009 711 722
49. L. Milane Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells Mol. Pharm. 8 2010 185 203
50. X.R. Song Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles Eur. J. Pharm. Sci. 37 2009 300 305
51. Y. Patil Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance J. Control. Release 136 2009 21 29
52. S. Parveen Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging Nanomedicine 8 2012 147 166
53. F. Dilnawaz Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy Biomaterials 31 2010 3694 3706
54. A. Singh Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy ACS Appl. Mater. Interfaces 3 2011 842 856
55. T.K. Jain Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging Biomaterials 29 2008 4012 4021
56. L. Serpe Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line Eur. J. Pharm. Biopharm. 58 2004 673 680 (Pubitemid 39297116)
57. H.L. Wong A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system J. Pharmacol. Exp. Ther. 317 2006 1372 1381
58. O. Taratula Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes Curr. Drug Deliv. 8 2011 59 69
59. H.L. Lu Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo J. Control. Release 155 2011 458 464
60. M. Longmire Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats Nanomedicine (Lond.) 3 2008 703 717
61. M.R. Longmire Biologically optimized nanosized molecules and particles: more than just size Bioconjug. Chem. 22 2011 993 1000
62. S.T. Stern, and S.E. McNeil Nanotechnology safety concerns revisited Toxicol. Sci. 101 2008 4 21 (Pubitemid 350239008)
63. N. Asare Cytotoxic and genotoxic effects of silver nanoparticles in testicular cells Toxicology 291 2012 65 72
64. I. Fenoglio Thickness of multiwalled carbon nanotubes affects their lung toxicity Chem. Res. Toxicol. 25 2012 74 82